Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. (“Magellan”), expanded the Class I recall of its LeadCare® II Blood Lead Test Kits, LeadCare Plus® Blood Lead T

Source: Food and Drugs Administration--Recalls/Safety Alerts